The impact of illicit drug use on Spontaneous Hepatitis C Clearance: Experience from a large cohort population study

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Poustchi, Hossein ^a   Esmaili, Saeed ^a   Mohamadkhani, Ashraf ^a   Nikmahzar, Aghbibi ^a   Pourshams, Akram ^a   Sepanlou, Sadaf G ^a   Merat, Shahin ^a   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; ILLICIT DRUG;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; IMMUNOBLOTTING; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; VIRAL CLEARANCE; ADDICTION; MIDDLE AGED; PATHOLOGY; REMISSION;

HEPATITIS C VIRUS;

COHORT STUDIES; FEMALE; HEPATITIS C; HUMANS; IRAN; MALE; MIDDLE AGED; REMISSION, SPONTANEOUS; SUBSTANCE-RELATED DISORDERS;

EID: 80051991366     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023830     Document Type: Article

References (52)

1. Centers for Disease Control and Prevention (1998) Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease MMWR Recomm. Rep 47: 1-39.
2. WHO Consultation Report (1999) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6: 35-47.
3. Shepard CW, Finelli L, Alter MJ, (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
4. Alavian SM, Ahmadzad-Asl M, Lankarani KB, Shahbabaie MA, Bahrami-Ahmadi A, et al. (2009) Hepatitis C infection in the general population of Iran: A systematic review. Hep Mon 9: 211-223.
5. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, et al. (2010) Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis 14 (Suppl 3): e113-116.
6. Javadzadeh-Shahshahani H, (2007) Comparison of the positive predictive value of two enzyme immunoassay screening kits for hepatitis C in blood donors. Sci J Iranian Blood Transfus Org Res Cent 4: 51-57.
7. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A, (2009) Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 49: 2214-2220.
8. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, et al. (2003) Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125: 80-88.
9. Kamal SM, (2008) Acute hepatitis C: a systematic review. Am J Gastroenterol 103-1283 1297 quiz 1298.
10. Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, et al. (2002) Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 50: 693-696.
11. Mazzeo C, Azzaroli F, Giovanelli S, Dormi A, Festi D, et al. (2003) Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut 52: 1030-1034.
12. Piasecki BA, Lewis JD, Reddy KR, Bellamy SL, Porter SB, et al. (2004) Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 40: 892-899.
13. Santantonio T, Sinisi E, Guastadisegni A, Casalino C, Mazzola M, et al. (2003) Natural course of acute hepatitis C: a long-term prospective study. Dig Liver Dis 35: 104-113.
14. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, et al. (2000) The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284: 450-456.
15. Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL, (1999) Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29: 908-914.
16. Blackard JT, Shata MT, Shire NJ, Sherman KE, (2008) Acute hepatitis C virus infection: a chronic problem. Hepatology 47: 321-331.
17. Maheshwari A, Ray S, Thuluvath PJ, (2008) Acute hepatitis C. Lancet 372: 321-332.
18. Singh R, Kaul R, Kaul A, Khan K, (2007) A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 13: 1770-1787.
19. Wang CC, Krantz E, Klarquist J, Krows M, McBride L, et al. (2007) Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 196: 1474-1482.
20. Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M, et al. (2006) Higher clearance of hepatitis C virus infection in females compared with males. Gut 55: 1183-1187.
21. Grebely J, Raffa JD, Lai C, Krajden M, Conway B, et al. (2007) Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol 21: 447-451.
22. Kenny-Walsh E, (1999) Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 340: 1228-1233.
23. Wietzke-Braun P, Manhardt LB, Rosenberger A, Uy A, Ramadori G, et al. (2007) Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlates. World J Gastroenterol 13: 4224-4229.
24. Aborsangaya KB, Dembinski I, Khatkar S, Alphonse MP, Nickerson P, et al. (2007) Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms. Hepatology 45: 623-630.
25. Alric L, Fort M, Izopet J, Vinel JP, Bureau C, et al. (2000) Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens 56: 154-158.
26. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801.
27. Page K, Hahn JA, Evans J, Shiboski S, Lum P, et al. (2009) Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis 200: 1216-1226.
28. Alter MJ, (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44: S6-9.
29. Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, et al. (2002) Protection against persistence of hepatitis C. Lancet 359: 1478-1483.
30. Shores NJ, Maida I, Soriano V, Nunez M, (2008) Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients. J Hepatol 49: 323-328.
31. Alavian SM, Adibi P, Zali M-R, (2005) Hepatitis C virus in Iran: epidemiology of an emerging infection. Arch Iran Med 8: 84-90.
32. Jabbari A, Besharat S, Khodabakhshi B, (2008) Hepatitis C in hemodialysis centers of Golestan province, northeast of Iran (2005). Hep Mon 8: 61-65.
33. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, et al. (2009) The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med 12: 225-231.
34. Vahdani P, Hosseini-Moghaddam S, Family A, Moheb-Dezfouli R, (2009) Prevalence of HBV, HCV, HIV, and syphilis among homeless subjects older than fifteen years in Tehran. Arch Iran Med 12: 483-487.
35. Vahdani P, Hosseini-Moghaddam S, Gachkar L, Sharifi K, (2006) Prevalence of hepatitis B, hepatitis C, human immunodeficiency virus, and syphilis among street children residing in southern Tehran, Iran. Arch Iran Med 9: 153-155.
36. Zakizad M, Salmeh F, Yaghoobi T, Yaghoubian M, Nesami MB, et al. (2009) Seroprevalence of hepatitis C infection and associated risk factors among addicted prisoners in Sari-Iran. Pak J Biol Sci 12: 1012-1018.
37. Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, et al. (2005) Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 40: 951-958.
38. Chung RT, (2005) Acute hepatitis C virus infection. Clin Infect Dis 41 (Suppl 1): S14-17.
39. Messick K, Sanders JC, Goedert JJ, Eyster ME, (2001) Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders. Haemophilia 7: 568-574.
40. Barrett S, Goh J, Coughlan B, Ryan E, Stewart S, et al. (2001) The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 49: 423-430.
41. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, et al. (2006) Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med 9: 319-323.
42. Pham ST, Bull RA, Bennett JM, Rawlinson WD, Dore GJ, et al. (2010) Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology 52: 1564-1572.
43. Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, et al. (2010) Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 138: 315-324.
44. Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, et al. (2008) High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 48: 1746-1752.
45. Grebely J, Conway B, Raffa JD, Lai C, Krajden M, et al. (2006) Hepatitis C virus reinfection in injection drug users. Hepatology 44: 1139-1145.
46. Lewis-Ximenez LL, Lauer GM, Schulze Zur Wiesch J, de Sousa PS, Ginuino CF, et al. (2010) Prospective follow-up of patients with acute hepatitis C virus infection in Brazil. Clin Infect Dis 50: 1222-1230.
47. Santantonio T, Medda E, Ferrari C, Fabris P, Cariti G, et al. (2006) Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis 43: 1154-1159.
48. Santana Rodriguez OE, Male Gil ML, HernandezSantana JF, Liminana Canal JM, Martin Sanchez AM, (1998) Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol 14: 555-561.
49. Inoue G, Horiike N, Michitaka K, Onji M, (2000) Hepatitis C virus clearance is prominent in women in an endemic area. J Gastroenterol Hepatol 15: 1054-1058.
50. Hayashi J, Kishihara Y, Ueno K, Yamaji K, Kawakami Y, et al. (1998) Age-related response to interferon alfa treatment in women vs men with chronic hepatitis C virus infection. Arch Intern Med 158: 177-181.
51. Yamakawa Y, Sata M, Suzuki H, Noguchi S, Tanikawa K, (1996) Higher elimination rate of hepatitis C virus among women. J Viral Hepat 3: 317-321.
52. Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, et al. (2010) Cohort Profile: The Golestan Cohort Study-a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 39: 52-59.